Avastin causing gastrointestinal perforations, new ovarian cancer trial enrolments suspended by Genentech Inc

... Genentech Inc decided not to enrol any more volunteers into its study of Avastin for the treatment of ovarian cancer because more people than they had expected had experienced gastrointestinal perforations - the suspension happened after the company met with the FDA. Our of 44 patients on the trial, five had gastrointestinal perforations... click link for more info. ...